Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer

摘要: There has been an impressive emergence of mass spectrometry based technologies applied toward the study proteins. Equally notable is rapid adaptation these to biomedical approaches in realm clinical proteomics. Concerted efforts elucidation proteomes organ sites or specific disease state are proliferating and from come promise better diagnostics/prognostics therapeutic intervention. Prostate cancer a focus many such studies with improved care patients via biomarkers derived proteomic approaches. The newer provide higher analytical capabilities, employ automated liquid handling systems, fractionation techniques bioinformatics tools for greater sensitivity resolving power, more robust throughput sample processing, confidence results. In this prospects, we summarize date prostate cancer, along their respective advantages disadvantages. development strategies use future applications also discussed.